Oncologix Tech Financials
| OCLG Stock | USD 0.0001 0.00 0.00% |
Oncologix |
Oncologix Tech Stock Summary
Oncologix Tech competes with China Teletech, Embrace Change, and A SPAC. Oncologix Tech, Inc., a diversified medical holding company, provides health care services in the United States. Oncologix Tech, Inc. was founded in 1995 and is based in Lafayette, Louisiana. Oncologix Tech operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 191 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US68230M2098 |
| Business Address | 1604 West Pinhook |
| Sector | Health Care Providers & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.oclghealth.com |
| Phone | 616 977 9933 |
| Currency | USD - US Dollar |
Oncologix Tech Key Financial Ratios
There are many critical financial ratios that Oncologix Tech's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Oncologix Tech reports annually and quarterly.| Return On Asset | -0.12 | |||
| Number Of Employees | 191 | |||
| Beta | 1.27 | |||
| Z Score | -47.6 |
Oncologix Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Oncologix Tech's current stock value. Our valuation model uses many indicators to compare Oncologix Tech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Oncologix Tech competition to find correlations between indicators driving Oncologix Tech's intrinsic value. More Info.Oncologix Tech is considered to be number one stock in return on asset category among its peers. It also is considered to be number one stock in profit margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Oncologix Tech's earnings, one of the primary drivers of an investment's value.Oncologix Tech Systematic Risk
Oncologix Tech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Oncologix Tech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Oncologix Tech correlated with the market. If Beta is less than 0 Oncologix Tech generally moves in the opposite direction as compared to the market. If Oncologix Tech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Oncologix Tech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Oncologix Tech is generally in the same direction as the market. If Beta > 1 Oncologix Tech moves generally in the same direction as, but more than the movement of the benchmark.
Complementary Tools for Oncologix Pink Sheet analysis
When running Oncologix Tech's price analysis, check to measure Oncologix Tech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncologix Tech is operating at the current time. Most of Oncologix Tech's value examination focuses on studying past and present price action to predict the probability of Oncologix Tech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncologix Tech's price. Additionally, you may evaluate how the addition of Oncologix Tech to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |